Sector ratings Bio-Rad Laboratories, Inc.

Stocks

Market Closed - NYSE 06:00:02 28/08/26 am AEST			5-day change	1st Jan Change
389.94 ^USD	+0.33%		+3.58%	+28.70%

07/08	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
05/08	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
BIO-RAD LABORATORIES, INC.	10.3B	BBB	-
ABBOTT LABORATORIES	193B	BBB
MEDTRONIC PLC	115B	BBB
CENCORA, INC.	61.3B	AA
HOYA CORPORATION	51.37B	AAA
BECTON, DICKINSON AND COMPANY	51.24B	A
DEXCOM, INC.	33.69B	BBB
MEDLINE INC.	30.4B	A
WEST PHARMACEUTICAL SERVICES, INC.	24.36B	AA
TERUMO CORPORATION	23.7B	AA
STERIS PLC	22.71B	AAA	-
SARTORIUS STEDIM BIOTECH	22.3B	BBB
ZIMMER BIOMET HOLDINGS, INC.	18.97B	A
SOLVENTUM CORPORATION	15.48B	BBB
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	15.44B	A
BAXTER INTERNATIONAL INC.	13.41B	A
ALIGN TECHNOLOGY, INC.	11.28B	A
GLOBUS MEDICAL, INC.	11.08B	CCC
REPLIGEN CORPORATION	10.27B	AA
INSULET CORPORATION	9.95B	A
Average	37.28B	A
Weighted average by Cap.		A